US Oncology News
Texas Oncology-Baylor Sammons Cancer Center Recognized for Highest Commitment to Clinical Research at ASCO
US Oncology Manufacturing-Inspired Practice Management Model Producing Quality and Efficiency Improvements
US Oncology Launches Oncology-Specific Billing and Reimbursement Service
Interim Data from Phase II Trial Presented by US Oncology Researchers at 44th Annual Meeting of the American Society of Clinical Oncology
US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings
US Oncology Reports 2008 First Quarter Results
US Oncology to Report 2008 First Quarter Earnings Results
US Oncology Practice Affiliates Recognized as Innovators at Cancer Center Business Summit
US Oncology Announces Resignation of Chief Financial Officer
US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results
US Oncology to Report 2007 Fourth Quarter and Year-End Earnings Results
91 Percent of Oncologists Polled Report Adverse Patient Events as Result of CMS National Coverage Decision on ESAs
US Oncology Announces Realignment of Executive Team
Advanced Medical Specialties Joins US Oncology Network
US Oncology Lloyd K. Everson, M.D., Selected to Participate in President’s Cancer Panel Roundtable
US Oncology Research Begins Phase II Study of Docetaxel plus Oxaliplatin with or without Cetuximab in Advanced Gastric Cancer and/or Gastroesophageal Junction Adenocarcinoma
US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium
Oral Presentation of the US Oncology Adjuvant Trial 9735 at 2007 San Antonio Breast Cancer Symposium Showed Taxotere® and Cyclophosphamide Improved Overall Survival Versus An Anthracycline Combination
US Oncology Appoints Glen Laschober EVP & Chief Operating Officer
BiPar Begins Phase II Study of Lead PARP Inhibitor in Triple-Negative Breast Cancer Base on Overexpression Biomarker Data
US Oncology Reports Third Quarter 2007 Results
US Oncology to Report 2007 Third Quarter Earnings Results
Cancer Doctors Across America “Stunned” At Government’s Ruling Restricting Anemia Management Protocols for Cancer Patients, Call Ruling “Interference” in Practice of Medicine
US Oncology Reports Second Quarter 2007 Results
US Oncology Postpones Announcement of 2007 Second Quarter Earnings Results
US Oncology to Report 2007 Second Quarter Earnings Results
Atul Dhir to Lead Rapidly Expanding Biopharmaceutical Services Group
US Oncology Reports First Quarter 2007 Results
US Oncology to Report 2007 First Quarter Earnings Results
US Oncology Named One of America’s Most Admired Companies -- Network Recognized for its Innovation, Use of Corporate Assets, Employee Management and Other Strengths
US Oncology Holdings, Inc. Announces Issuance of $425 Million of Debt Securities
US Oncology Implements Nationwide Pharmaceutical Supply Chain Pedigree -- Ensures drugs distributed in network are secure from counterfeit; improves supply chain management and efficiency
US Oncology Honors Oncology Nurse and Radiation Oncology & Imaging Professionals for Leadership and Service
Dr. Luis Munoz Named President of the American College of Radiation Oncology
US Oncology Reports Fourth Quarter and Fiscal Year 2006 Results
US Oncology Holdings, Inc. Announces Proposed Sale of Senior Floating Rate PIK Toggle Notes
US Oncology to Report 2006 Fourth Quarter and Year-End Earnings Results
Study Published in British Medical Journal The Lancet Shows Aromasin Improves Overall Survival in Breast Cancer Patients
PRA International and US Oncology Enter Strategic Alliance
Local Oncology Group to Open Cancer Care Center, Increasing Patient Access to Vital Elements of Care
US Oncology Holdings, Inc. Announces Completion of Equity Offering and Declaration of Dividend to Stockholders
Equity Offering by US Oncology Holdings, Inc.
US Oncology Reports Results For Third Quarter 2006
US Oncology to Report Third Quarter 2006 Earnings Results
Daniel S. Lynch Appointed to US Oncology Board
US Oncology Reports Results for Second Quarter 2006
US Oncology and Molecular Profiling Institute Enter Venture to Accelerate the Development of Personalized Cancer Treatments
US Oncology Names Richard McCook New CFO
US Oncology to Bring Oncology-Focused Specialty Pharmacy Services to Cancer Patients
President Bush Appoints US Oncology’s Lloyd K. Everson M.D.
US Oncology to Report Second Quarter 2006 Earnings Results
US Oncology Announces Completion of $100 Million Incremental Term Loan Facility.
New York Oncology Hematology and Rocky Mountain Cancer Centers Receive Clinical Trial Participation Awards at ASCO Annual Meeting
Docetaxel and Oxaliplatin Study Shows Promise as a Treatment for Patients with Gastroesophageal and/or Stomach Cancer
Better Survival Seen for Early Breast Cancer Patients Switched from Tamoxifen to Pfizer’s Aromasin® (exemestane tablets)
US Oncology Reports Results For First Quarter 2006
US Oncology to Report First Quarter 2006 Earnings Results
US Oncology Honors Oncology Nurses for Leadership and Service
US Oncology Reports Fourth Quarter and 2005 Year-End Results
NABP Accredits First Two Wholesale Distributors through VAWD Program: CVS/pharmacy’s Indiana Distribution Center and US Oncology Specialty, LP
US Oncology Research Network Presents Clinical Studies at ASCO Gastrointestinal Cancers Symposium
New Study Demonstrates Nonanthracycline Adjuvant Regimen TC (Docetaxel and Cyclophosphamide) is Superior to Standard AC (Doxorubicin/Cyclophosphamide) for Early Breast Cancer
US Oncology Research Network Presenting Numerous Studies at San Antonio Breast Cancer Symposium
US Oncology Reports Results for Third Quarter 2005
US Oncology to Report 2005 Third Quarter Earnings
US Oncology Reports Anticipated Financial Results for Third Quarter 2005
US Oncology Appoints Bruce D. Broussard as President
Central Indiana Cancer Centers Cited by Indianapolis Medical Society for Community Service
US Oncology Reports Financial Results for Second Quarter 2005
US Oncology to Report 2005 Second Quarter Earnings
US Oncology Enters Pharmaceutical Distribution Business
Three US Oncology Network Practices Receive Clinical Trial Participation Awards at 2005 ASCO Annual Meeting
US Oncology Reports Financial Results for First Quarter 2005
US Oncology to Report 2005 First Quarter Earnings
Issuance of New Debt Securities of US Oncology Holdings, Inc.
New Debt Securities of US Oncology Holdings, Inc.
US Oncology Expands Network with the Addition of Northwestern Connecticut Oncology and Hematology Associates
US Oncology Reports Financial Results for Fourth Quarter and Combined Year-End Results for 2004
US Oncology Plays Important Ongoing Role in Newly Approved Abraxane™, the First Albumin-Bound Nanoparticle Paclitaxel for the Treatment of Metastatic Breast Cancer
Texas Oncology, P.A. Brings Expanded Cancer Care to Residents of Collin County
Dr. Gerardo H. Trillo to Lead Texas Oncology, P.A. Frisco Office
US Oncology Gets Stockholder Approval, Completes its Tender Offer and Closes Merger with Oiler Acquisition Corp.
US Oncology Extends Tender Offer and Consent Solicitation for its 9 5/8% Senior Subordinated Notes Due 2012
US Oncology Reports Financial Results for Second Quarter 2004US Oncology, Inc. (Nasdaq: USON) today reported results for the 2004 second quarter
US Oncology Extends Tender Offer and Consent Solicitation for its 9 5/8% Senior Subordinated Notes Due 2012
US Oncology Announces Receipt of Requisite Consents and Extends Tender Offer and Consent Solicitation for Its 9 5/8% Senior Subordinated Notes Due 2012
US Oncology Researchers Play Key Role in Promising Clinical Trials of the Investigational Agent AbraxaneTM
US Oncology Extends Tender Offer and Consent Solicitation for Its 9 5/8% Senior Subordinated Notes Due 2012
Two US Oncology-Affiliated Practices Win Prestigious ASCO Clinical Trials Participation Award
Arizona Nurse Wins US Oncology 2004 Pearl Moore Excellence in Nursing Leadership Award
US Oncology Honors Texas Nurse With 2004 Betsy York AwardMichelle Grodi, R.N., O.C.N., receives national award for oncology nursing excellence
US Oncology Commences Tender Offer and Consent Solicitation for Its 9 5/8% Senior Subordinated Notes Due 2012
US Oncology Reports Financial Results for First Quarter 2004
US Oncology to Report 2004 First Quarter Financial Results April 29
US Oncology Announces Filing of Lawsuits Concerning Merger Agreement with Affiliate of Welsh, Carson, Anderson & Stowe
US Oncology Signs Merger Agreement for $15.05 Cash Per Share; Welsh, Carson, Anderson & Stowe to Lead Buyout
US Oncology Plays Pivotal Role in Testing of Newly Approved Colon Cancer Therapy, Avastin
US Oncology Reports Fourth Quarter and Year-end Results for 2003
US Oncology Announces Transition of Three Practices to the Earnings Model
US Oncology to Discuss Company Strategy and Operations at UBS Global Healthcare Services Conference
US Oncology to Provide Latest Company Update at JP Morgan Healthcare Conference
2003 News Archives Appear Below
US Oncology Issues Statement Regarding Impact of Legislation Relating to Reimbursement for Prescription Drugs Under Medicare
US Oncology Reports Third Quarter 2003 Financial Results
US Oncology Names 2003 Pearl Moore Excellence in Nursing Leadership Award Winner
US Oncology to Provide Oncology Pharmaceutical Services to Physician Practice in Central Florida
US Oncology to Report 2003 Third Quarter Financial Results October 30
US Oncology to Provide Latest Company Update at Deutsche Bank Global High Yield Conference
US Oncology Board Authorizes $50 Million in Share Repurchases
US Oncology Reports Financial Results for Second Quarter 2003
US Oncology to Report 2003 Second Quarter Financial Results August 7
US Oncology Providing Affiliated Practices Advanced Radiation Therapy Technology
US Oncology to Assist Congressional Committee
US Oncology Reports Financial Results for First Quarter 2003
TOPA Begins Construction of Comprehensive Cancer Care Facility in Sugar Land
US Oncology to Report 2003 First Quarter Financial Results May 9
US Oncology Expands Cancer Center Network with Fourth Comprehensive Center in Indianapolis Area
US Oncology Opens New Cancer Center in Dayton, Ohio Area
US Oncology Among the Most Admired Companies in America
US Oncology Reports Fourth Quarter and Year-end Results for 2002
US Oncology to Provide Company Update at Raymond James Institutional Investors Conference
BrainLAB Inc. Signs Preferred Vendor Agreement for Patient Positioning and Visualization Technology Systems with US Oncology
US Oncology to Report 2002 Fourth Quarter and Year-end Financial Results Feb. 27
US Oncology Names New Sr. VP of Marketing and Development
2002 News Archives Appear Below
US Oncology to Provide Company Update at JP Morgan H&Q Healthcare Conference
Study Concludes Adding Paraplatin Enhanced Effectiveness of Current Treatment for Advanced Breast Cancer
Texas Cancer Center-Abilene Launches First Mobile PET Unit in the Area
US Oncology Expands PET Network with New Systems in Texas and Illinois
US Oncology Expands Cancer Center Network with Second Center in Kansas City Area
US Oncology Board Authorizes $50 Million in Share Repurchases
US Oncology Reports Financial Results for Third Quarter 2002
GE Medical Systems Installs 300th Positron Emission Tomography System
US Oncology Employees Help Raise Breast Cancer Awareness at Race for the Cure
US Oncology to Report 2002 Third Quarter Financial Results October 31
Young Cancer Patients Benefit from US Oncology's Saturday of Service
Jennifer Barolo Honored with National Oncology Nursing Award
Latest US Oncology Business Update Set for Deutsche Bank Global Conference
US Oncology Launches Clinical Trial of New Combination Chemotherapy Treatment for Breast Cancer
Cory Stevenson Joins US Oncology to Lead Pharmaceutical Services
US Oncology CEO and CFO Sign Sworn Statements Regarding Company’s Financial Statements
US Oncology Reports Financial Results for Second Quarter 2002
US Oncology Presents the First Pearl Moore Award for Leadership in Nursing
Oncology Nurses from Around the Country to Discuss Cancer Care Issues
US Oncology 2002 Second Quarter Financial Results to be Released July 30
US Oncology Taking Part in One of the Largest Clinical Trials for Early Stage Breast Cancer
US Oncology to Present at National Securities Conference
Data in JCO Point to Significant Survival Advantages for Metastatic Breast Cancer Patients
US Oncology Board Authorizes $35 Million in Share Repurchases
US Oncology to Provide Business Update at National Securities Conference
US Oncology Reports Financial Results for First Quarter 2002
US Oncology Presents Third Annual Cancer Medal of Honor Awards
US Oncology 2002 First Quarter Financial Results to be Released May 2
US Oncology to Provide Business Update at National Cancer Conference
US Oncology Installs 13th Positron Emission Tomography Unit
Amgen Signs Multi-Year Contract With US Oncology
Patients to Benefit from CMS Decision to Expand PET Technology Coverage for Recurrent Breast Cancer
US Oncology Reports Fourth Quarter and Year-end Results for 2001
US Oncology to Release 2001 Fourth Quarter Results Feb. 27
PDGF and FGF Receptor Families of Tyrosine Kinases: Role in Anticancer Therapy
The US Oncology Advocate -- Winter 2002
US Oncology, Inc. Completes Private Placement of $175 Million of Senior Subordinated Notes
US Oncology to Present at UBS Warburg Healthcare Conference
US Oncology to Provide Corporate Update at leading Health Care Conference
US Oncology Reports Clinical Trial Results Point to Potential New Treatment Option for Metastatic Pancreatic Cancer
US Oncology to Make Private Placement of $175 Million Senior Subordinated Notes
US Oncology to Present at JPMorgan H&Q Healthcare Conference
2001 News Archives Appear Below
US Oncology Installs Mobile PET Units to Serve East Texas and Rio Grande Valley Regions of Texas
Physician Recruiting: How to get the right Doctor for your Practice
VEGF Receptor Family of Tyrosine Kinases: Role in Anticancer Therapy
Legislative Alert - Message to Congress: Pass Balanced Medicare Reform!
Significant Survival Advantages for Chemotherapy Combination in Metastatic Breast Cancer Patients
US Oncology Opens Cancer Center in Kansas City Area
The US Oncology Advocate -- Fall 2001
Lung Cancer Research Papers From Four US Oncology Affiliated Physicians Selected as 'Classics'
US Oncology Announces Practice Conversions to Earnings Model
US Oncology Reports Third Quarter 2001 Results
EGFR Tyrosine Kinase Inhibitors as Anticancer Agents
Physician Compensation Stark II
NEW COVERED INDICATIONS FOR PET SCAN
The GAO Analysis of Practice Expenses and Patient Access: Complete the Study!
It’s time to look closely at your relationships with pharmaceutical companies
US Oncology Opens Mobile PET Facility In Chicago Area
US Oncology Announces Earnings Release Date of November 1
US Oncology Announces Opening Of Its Newest Cancer Center In Vancouver, Washington
GE Medical Systems and US Oncology Sign Strategic Multi-Year Partnership Agreement
US Oncology to Expand Core Services to Non-Affiliated Oncologists and Transition Away From Traditional PPM Business
US Oncology Announces Net Conference Date of October 1
US Oncology to Present at Raymond James & Associates Healthcare Conference
Two US Oncology Transplant Programs Earn FAHCT Accreditation
LegislativeAlert: Are We on the Road to Reform?
US Oncology Opens Its Ninth PET Center in Greenville, South Carolina; PET Facility is the First in the Upstate South Carolina Region
The US Oncology Advocate -- Summer 2001
Managed Care Trends
Future Trends in Clinical Research
US Oncology Reports Second Quarter 2001 Results; Second Quarter Produces EPS of $0.13
US Oncology Announces Opening of 75th Cancer Center and 8th PET Facility
Breast Cancer Research Papers From Six US Oncology Affiliated Physicians Selected as 'Classics'
William Herman Joins US Oncology as Vice President - Radiation Services
Dr. John Nemunaitis to Appear on ABC Network News Special
US Oncology to Open PET Centers in Indianapolis and Austin; Indianapolis Facility is Company's First Mobile Unit
US Oncology Featured in Modern Healthcare Cover Story
Ribozyme and Chiron Commence Phase II Angiozyme Colorectal Cancer Trial
US Oncology Urges Children to Ask Dads On Father's Day to Have Prostate Cancer Test
US Oncology Announces Personnel Changes
US Oncology President Promoted to Vice Chairman; Chairman, CEO Ross Adds President Title to Responsibilities
US Oncology Names Robert Jordan Vice President of Human Resources
Three-Time Cancer Survivor and US Oncology Scholarship Recipient Graduates
US Oncology Reports Taxol -- Paclitaxel -- Based Chemotherapy is Safe and Effective in Hormone-Refractory Prostate Cancer Patients
US Oncology Moves Forward With PET Center Expansion; Spokane Facility is Company's Fifth
New Technology at Texas Oncology, P.A. at Klabzuba Gives New Hope in Fighting Brain Tumors
US Oncology Announces Opening of Two New Cancer Centers
US Oncology Announces Practice Conversions to Net Earnings Model; Three Oncology Practices Adopt Affiliation Agreement
America's Oncology Nurses Video Wins Gold!
eResearchTechnology, Inc. Signs a $3 Million Contract to Supply US Oncology, Inc. with its Integrated Suite of Software and Services for Speeding Drug Development in Clinical Research
US Oncology Reports 2000 Results
US Oncology Announces Practice Conversion to Net Earnings Model
Cell Pathways Initiates Phase III Clinical Trial in Non-Small Cell Lung Cancer
US Oncology Practices Convert to Net Earnings Model
US Oncology Announces Presentation At Upcoming Healthcare Conferences
INEX Pharmaceuticals ONCO TCS Pivotal Clinical Trial Initiated at US Oncology Community Cancer Centers
US Oncology Announces Opening Of Two Cancer Centers
2000 News Archives Appear Below
US Oncology Announces Opening of Cancer Centers in Littleton, CO and Denton, TX
US Oncology Implements Three PET Centers
WEEKLY CHEMOTHERAPY IS AN EFFECTIVE TREATMENT FOR ADVANCED BREAST CANCER PATIENTS
New Study Shows Survival Advantage of Chemotherapy Combination in Patients with Metastatic Breast Cancer
Inex Pharmaceuticals Releases Third Quarter Report
US Oncology Names George Morgan as Senior Vice President of National Operations
USON Announces PET Financing Arrangements
US Oncology to host national nursing forum on cancer care
